Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
5.65
+0.30 (5.61%)
At close: Jun 6, 2025, 4:00 PM
5.50
-0.15 (-2.65%)
After-hours: Jun 6, 2025, 7:54 PM EDT

Kazia Therapeutics Revenue

In the fiscal year ending June 30, 2024, Kazia Therapeutics had annual revenue of 2.48M AUD with 248,000.00% growth. Kazia Therapeutics had revenue of 2.48M in the half year ending June 30, 2024.

Revenue (ttm)
2.48M AUD
Revenue Growth
+248,000.00%
P/S Ratio
1.80
Revenue / Employee
275,667 AUD
Employees
9
Market Cap
6.32M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20242.48M2.48M248,000.00%
Jun 30, 20231,000.00-9.00K-90.00%
Jun 30, 202210.00K-15.17M-99.93%
Jun 30, 202115.18M14.19M1,436.54%
Jun 30, 2020988.11K-451.89K-31.38%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.